Reported Earlier, ProKidney Prices Upsized $130M Public Offering Of 53,719,009 Class A Ordinary Shares At $2.42/Share And Concurrent Registered Direct Offering
All of the Class A ordinary shares in the underwritten public offering and concurrent registered direct offering are being sold by the Company. The public offering and the concurrent registered direct offering are each expected to close on or about June 13, 2024, subject to customary closing conditions.